Japanese CTO PCI Expert Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorKurashiki Central Hospital
About this trial
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Thrombolysis in myocardial infarction trial (TIMI) 0
The occlusive period more than 3 months or unknown
The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
Disqualifiers
None
Trial population
Patients who underwent PCI for CTO lesions by Japanese certified operators
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
19,000 Participants
are grouped into 1 trial groupGroup A: PCI for CTO
Trial outcomes
Primary outcomes
1
successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up
early and late results on major adverse cardiocerebral events (MACCE): all-cause death, coronary artery bypass grafting, re-PCI (target lesion revascularization/target vessel revascularization), admission for heart failure, myocardial infarction, admission for unstable angina, cerebrovascular disease, stent thrombosis in 19000 patients in and outside Japan
Time frame
within the first 1 month (plus 1 month) after PCI and during the 5-year follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Kurashiki Central Hospital
Lead sponsor
Japanese CTO PCI Expert Registry investigators
Collaborator
Source ClinicalTrials.gov